Skip to main content
. Author manuscript; available in PMC: 2013 Dec 17.
Published in final edited form as: Clin Genitourin Cancer. 2009 Aug;7(2):10.3816/CGC.2009.n.015. doi: 10.3816/CGC.2009.n.015

Table 4.

Response Rates and Survival

Statistic CrCl ≤
60 mL/min
(n = 14)		 CrCl >
60 mL/min
(n = 18)
Response Rate, % 14 (90% CI, 4–37) 33 (90% CI, 16–54)
Median TTP, Months 3.2 (90% CI, 2.6–4.9) 4.7 (90% CI, 3.6–6.1)
6-Month TTP Rate, % 17 (90% CI, 0- 36) 34 (90% CI, 11- 56)
Median Survival, Months 12.3 (90% CI, 6.8–16.9) 11.1 (90% CI, 5.2–18.2)
12-Month OS Rate, % 51 (90% CI, 28–73) 48 (90% CI, 29–67)
24-Month OS Rate, % 16 (90% CI, 0–36) 25 (90% CI, 8–43)

Abbreviations: CrCl = creatinine clearance; OS = overall survival; TTP = time to progression